Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation
Background Phosphatidylinositol binding clathrin assembly protein interacting mitotic regulator (PIMREG) expression is upregulated in a variety of cancers. However, its potential role in breast cancer (BC) remains uncertain. Methods The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) da...
Main Authors: | Wenjing Zhao, Yuanjin Chang, Zhaoye Wu, Xiaofan Jiang, Yong Li, Ruijin Xie, Deyuan Fu, Chenyu Sun, Ju Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-07-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/15703.pdf |
Similar Items
-
High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
by: Feng Jiang, et al.
Published: (2021-07-01) -
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
by: Hua Zhu, et al.
Published: (2021-09-01) -
PIMREG is a prognostic biomarker involved in immune microenvironment of clear cell renal cell carcinoma and associated with the transition from G1 phase to S phase
by: Huibao Yao, et al.
Published: (2023-01-01) -
Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
by: Hua Zhu, et al.
Published: (2022-07-01) -
Identification of Immune-Related Therapeutically Relevant Biomarkers in Breast Cancer and Breast Cancer Stem Cells by Transcriptome-Wide Analysis: A Clinical Prospective Study
by: Linbang Wang, et al.
Published: (2021-02-01)